DashboardPortfoliosWatchlistCommunityDiscoverScreener
NOT FOR DISTRIBUTION
Loading...
  • Stocks
  • /
  • Materials
Updated 2h ago
SCL logo

Stepan CompanyNYSE:SCL Stock Report

Market Cap US$1.4b
Updated 2h ago
Share Price
n/a
1Y28.0%
7D-2.9%
1D-0.1%
Portfolio Value
​
View

Stepan Company

NYSE:SCL Stock Report

Market Cap: US$1.4b

  • Company Overview
  • Valuation
  • Future Growth
  • Past Performance
  • Financial Health
  • Dividend
  • Management
  • Ownership
  • Other Information
  • Stock Community

Stepan (SCL) Stock Overview

Produces and sells specialty and intermediate chemicals to other manufacturers for use in various end products in the United States, France, Poland, the United Kingdom, Brazil, Mexico, and internationally. More details

SCL fundamental analysis
Snowflake Score
Valuation5/6
Future Growth3/6
Past Performance0/6
Financial Health4/6
Dividends3/6

Rewards

Trading at 60.9% below our estimate of its fair value

Earnings are forecast to grow 204.05% per year

Trading at good value compared to peers and industry

Risk Analysis

Dividend of 2.57% is not well covered by earnings or free cash flows

Has a high level of debt


SCL Community Fair Values

Create Narrative

See what 8 others think this stock is worth. Follow their fair value or set your own to get alerts.

Analyst Price Targets

AN
AnalystConsensusTarget
27.6% undervalued intrinsic discount
AnalystConsensusTarget
•1mo ago

Pasadena Site And Tech Integration Will Unlock Future Opportunities

256
0
6

Top Analyst Narratives

SCL logo
Stepan
27.6% undervalued intrinsic discount

Pasadena Site And Tech Integration Will Unlock Future Opportunities

View narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget
Updated 7 Aug
Read Narrative
View all narratives

Stepan Company Competitors

Minerals Technologies

Symbol: NYSE:MTX
Market cap: US$2.2b

Innospec

Symbol: NasdaqGS:IOSP
Market cap: US$2.3b

Quaker Chemical

Symbol: NYSE:KWR
Market cap: US$2.7b

H.B. Fuller

Symbol: NYSE:FUL
Market cap: US$2.8b

Price History & Performance

Summary of share price highs, lows and changes for Stepan
Historical stock prices
Current Share PriceUS$61.57
52 Week HighUS$68.00
52 Week LowUS$41.82
Beta0.94
1 Month Change-5.19%
3 Month Change13.01%
1 Year Change27.98%
3 Year Change-24.69%
5 Year Change-44.80%
Change since IPO11,363.22%

Recent News & Updates

Analysis Article • Aug 08

Results: Stepan Company Beat Earnings Expectations And Analysts Now Have New Forecasts

Stepan Company ( NYSE:SCL ) defied analyst predictions to release its second-quarter results, which were ahead of...
User avatar
Narrative Update • Aug 07

SCL: Higher Margin Assumptions Will Support Long-Term Dividend Upside

Analysts have raised their price target for Stepan from $75 to $85, citing updated assumptions that include a lower discount rate, an increased profit margin of 10.80%, and a more conservative future P/E of 8.05x. What’s in the News for Stepan Stepan Company was added to the Russell 2000 Dynamic Index as an index constituent.

Recent updates

Analysis Article • Aug 08

Results: Stepan Company Beat Earnings Expectations And Analysts Now Have New Forecasts

Stepan Company ( NYSE:SCL ) defied analyst predictions to release its second-quarter results, which were ahead of...
User avatar
Narrative Update • Aug 07

SCL: Higher Margin Assumptions Will Support Long-Term Dividend Upside

Analysts have raised their price target for Stepan from $75 to $85, citing updated assumptions that include a lower discount rate, an increased profit margin of 10.80%, and a more conservative future P/E of 8.05x. What’s in the News for Stepan Stepan Company was added to the Russell 2000 Dynamic Index as an index constituent.
Seeking Alpha • Jul 10

Stepan Company's Discount Isn't Over Yet

Summary Stepan Company remains a 'buy' due to attractive valuation, despite recent underperformance versus the S&P 500. Recent results show mixed fundamentals: revenue growth driven by Surfactants, but profitability pressured by restructuring charges and raw material costs. Project Catalyst targets $100 million in pre-tax cost savings over two years, with 60% expected this year and the remainder next. SCL’s strategy focuses on expanding share in large, growing addressable markets across Surfactants and Polymers, supporting long-term upside. Read the full article on Seeking Alpha
User avatar
Narrative Update • Jun 18

SCL: Stable Margins And Outlook Will Support Long-Term Dividend Upside

Analysts have kept their Stepan price target steady at $75, citing largely unchanged assumptions for fair value, discount rate, revenue growth, profit margin, and future P/E as the basis for this reaffirmed view. What’s in the News for Stepan No recent Stepan news items were identified in the provided primary news source.
User avatar
Narrative Update • Jun 04

SCL: Higher Margins And Revenue Outlook Will Support Long-Term Dividend Upside

Analysts have raised their price target for Stepan to $75.00, with the shift supported by updated assumptions for slightly lower discount rates, expectations of higher revenue, stronger profit margins, and a reduced future P/E multiple. What's in the News No recent company specific news items, periodical coverage, or key developments were provided for Stepan in the supplied sources.
User avatar
Narrative Update • Apr 28

SCL: Stable Margins And Buybacks Will Support Long-Term Dividend Upside

Analysts kept their fair value estimate steady at $75, with only marginal tweaks to the discount rate, revenue growth, profit margin, and future P/E assumptions. This indicates a largely unchanged view of Stepan's longer term potential.
User avatar
Narrative Update • Apr 12

SCL: Stable Margins And Buyback Completion Will Support Long-Term Dividend Upside

Analysts have nudged their Stepan price target slightly higher to $75.00, with modest tweaks to the discount rate and P/E assumptions supporting this updated view. What's in the News For the three months ended December 31, 2025, Stepan Company reported unaudited goodwill impairment of $6,245,000, which directly affects reported earnings quality for that period (Key Developments).
User avatar
Narrative Update • Mar 28

SCL: Steady Fair Value And Margins Will Support Long-Term Dividend Upside

Analysts have maintained their Stepan fair value estimate at $75.00, making only small adjustments to the discount rate, revenue growth, profit margin and future P/E assumptions. This signals that their overall view on the stock’s longer-term potential remains largely unchanged.
User avatar
Narrative Update • Mar 14

SCL: Steady Fair Value And Margins Will Support Long-Term Dividend Upside

Analysts have modestly revised their price outlook for Stepan, keeping fair value around $75.00 while making small tweaks to the discount rate and projected P/E. This reflects updated assumptions about the risk profile and valuation multiples rather than a shift in the underlying growth or margin view.
User avatar
Narrative Update • Feb 27

SCL: Higher Future P/E Assumptions Will Support Long-Term Dividend Upside

Analysts have adjusted their Stepan price target to $75.00, with the change tied to updated views on discount rate, revenue growth, profit margin, and a higher assumed future P/E multiple. What's in the News Stepan Company reported an unaudited goodwill impairment of $6,245,000 for the three months ended December 31, 2025.
User avatar
Narrative Update • Feb 11

SCL: Refined Discount Rate Assumptions Will Support Long-Term Dividend Upside

Analysts have kept their Stepan price target steady at $75.00, citing only slight tweaks to assumptions like discount rate, revenue growth, profit margin, and future P/E that were not material enough to change their overall valuation view. Valuation Changes Fair Value: Steady at $75.00, indicating no change in the analysts' central valuation estimate.
Analysis Article • Feb 04

Why Investors Shouldn't Be Surprised By Stepan Company's (NYSE:SCL) 26% Share Price Surge

Despite an already strong run, Stepan Company ( NYSE:SCL ) shares have been powering on, with a gain of 26% in the last...
User avatar
Narrative Update • Jan 27

SCL: Higher Discount Rate Will Set Up Attractive Long-Term Dividend Returns

Analysts now estimate Stepan's fair value at US$75.00, reduced from US$82.21. This change reflects updated assumptions regarding a higher discount rate, revised profit margin expectations, a slightly higher revenue growth outlook, and a lower future P/E multiple.
Analysis Article • Jan 08

Stepan (NYSE:SCL) May Have Issues Allocating Its Capital

To find a multi-bagger stock, what are the underlying trends we should look for in a business? Amongst other things...
Analysis Article • Dec 12

Why Stepan Company (NYSE:SCL) Could Be Worth Watching

Stepan Company ( NYSE:SCL ), is not the largest company out there, but it saw a double-digit share price rise of over...
Analysis Article • Nov 04

Stepan (NYSE:SCL) Will Pay A Larger Dividend Than Last Year At $0.395

Stepan Company's ( NYSE:SCL ) periodic dividend will be increasing on the 15th of December to $0.395, with investors...
Analysis Article • Sep 04

Here's What's Concerning About Stepan's (NYSE:SCL) Returns On Capital

What trends should we look for it we want to identify stocks that can multiply in value over the long term? Firstly...
Analysis Article • Jul 31

Is It Time To Consider Buying Stepan Company (NYSE:SCL)?

While Stepan Company ( NYSE:SCL ) might not have the largest market cap around , it received a lot of attention from a...
Analysis Article • Jun 10

Earnings Tell The Story For Stepan Company (NYSE:SCL)

Stepan Company's ( NYSE:SCL ) price-to-earnings (or "P/E") ratio of 22.5x might make it look like a sell right now...
Analysis Article • May 02

Results: Stepan Company Exceeded Expectations And The Consensus Has Updated Its Estimates

A week ago, Stepan Company ( NYSE:SCL ) came out with a strong set of first-quarter numbers that could potentially lead...
Seeking Alpha • Apr 20

Stepan Company's Plunge Offers Investors A Chance To Clean Up

Summary Markets are inefficient short-term, creating opportunities for logical, value-oriented investors; Stepan Company is now a ‘buy’ due to recent price drops and management's positive outlook. Despite a 6% revenue drop in 2024, Stepan Company improved net income and EBITDA, driven by cost-cutting measures and productivity improvements. Management is optimistic about 2025, expecting volume growth, margin improvement, and positive free cash flow, targeting high-margin, growth-oriented markets. Analysts forecast revenue and earnings growth for Q1 2025; shares are attractively priced compared to peers, justifying an upgrade to a ‘buy’ rating. Read the full article on Seeking Alpha
Analysis Article • Apr 16

Should You Investigate Stepan Company (NYSE:SCL) At US$47.60?

While Stepan Company ( NYSE:SCL ) might not have the largest market cap around , it received a lot of attention from a...
Seeking Alpha • Feb 04

Stepan Company: A 'Moderate Buy' Despite A High Valuation

Summary Stepan Company, a specialty chemicals manufacturer, excels in operational efficiency and dividend growth, making it a stable investment despite current valuations. Q3 FY24 financials show margin expansion and significant net income growth, despite a 3% revenue decline, highlighting fiscal discipline. Trading at a forward P/E of 17.3x for 2025, Stepan's stock has a potential 26% upside, making it a promising investment opportunity. I am an investment analyst with a focus on income generation. Read the full article on Seeking Alpha
Analysis Article • Jan 18

Shareholders Should Be Pleased With Stepan Company's (NYSE:SCL) Price

With a price-to-earnings (or "P/E") ratio of 31.4x Stepan Company ( NYSE:SCL ) may be sending very bearish signals at...
Analysis Article • Nov 26

These 4 Measures Indicate That Stepan (NYSE:SCL) Is Using Debt Extensively

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Analysis Article • Nov 02

Stepan's (NYSE:SCL) Upcoming Dividend Will Be Larger Than Last Year's

The board of Stepan Company ( NYSE:SCL ) has announced that the dividend on 13th of December will be increased to...
Seeking Alpha • Oct 30

Stepan Company: Not A Great Performance, But Good Value

Summary Stepan Company, despite underperformance and volatility, has long-term upside due to its unique position in the specialty chemicals market, particularly surfactants. The company's fundamentals have improved with reduced CapEx and positive FCF, but current earnings and macro pressures persist. SCL's growth potential is tied to the surfactant segment and market diversification, though the timing of earnings recovery remains uncertain. I rate Stepan as a "Buy" with a $90 PT, but caution that there are superior investments in the chemicals sector with better returns. Read the full article on Seeking Alpha

Shareholder Returns

SCLUS ChemicalsUS Market
7D-2.9%-3.8%-2.2%
1Y28.0%0.6%13.1%

Return vs Industry: SCL exceeded the US Chemicals industry which returned 0.6% over the past year.

Return vs Market: SCL exceeded the US Market which returned 13.1% over the past year.

Price Volatility

Is SCL's price volatile compared to industry and market?
SCL volatility
SCL Average Weekly Movement4.9%
Chemicals Industry Average Movement5.7%
Market Average Movement6.9%
10% most volatile stocks in US Market15.4%
10% least volatile stocks in US Market2.9%

Stable Share Price: SCL has not had significant price volatility in the past 3 months compared to the US market.

Volatility Over Time: SCL's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19322,328Luis Rojowww.stepan.com

Stepan Company, together with its subsidiaries, produces and sells specialty and intermediate chemicals to other manufacturers for use in various end products in the United States, France, Poland, the United Kingdom, Brazil, Mexico, and internationally. It operates through three segments: Surfactants, Polymers, and Specialty Products. The Surfactants segment offers surfactants that are used in consumer and industrial cleaning and disinfection products, including detergents for washing clothes, dishes, carpets, and floors and walls, as well as shampoos and body washes; and other applications, such as fabric softeners, germicidal quaternary compounds, disinfectants, lubricating ingredients; emulsifiers for spreading agricultural products; and industrial applications comprising latex systems, plastics, and composites.

Stepan Company Fundamentals Summary

How do Stepan's earnings and revenue compare to its market cap?
SCL fundamental statistics
Market capUS$1.40b
Earnings (TTM)-US$2.65m
Revenue (TTM)US$2.43b
0.6x
P/S Ratio
-527.8x
P/E Ratio

Is SCL overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
SCL income statement (TTM)
RevenueUS$2.43b
Cost of RevenueUS$2.15b
Gross ProfitUS$287.37m
Other ExpensesUS$290.03m
Earnings-US$2.65m

Last Reported Earnings

Jun 30, 2026

Next Earnings Date

n/a

Earnings per share (EPS)-0.12
Gross Margin11.81%
Net Profit Margin-0.11%
Debt/Equity Ratio53.4%

How did SCL perform over the long term?

See historical performance and comparison

Dividends

2.6%
Current Dividend Yield
-1,355%
Payout Ratio

Does SCL pay a reliable dividends?

See SCL dividend history and benchmarks
When do you need to buy SCL by to receive an upcoming dividend?
Stepan dividend dates
Ex Dividend DateSep 01 2026
Dividend Pay DateSep 15 2026
Days until Ex dividend11 days
Days until Dividend pay date3 days

Does SCL pay a reliable dividends?

See SCL dividend history and benchmarks

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/09/11 22:09
End of Day Share Price 2026/09/11 00:00
Earnings2026/06/30
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
  • SEC Form 10-K
  • SEC Form 10-Q
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
  • Analyst Research Reports
  • Blue Matrix
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
  • ICE Market Data
  • SEC Form S-1
Ownership10 years
  • Top shareholders
  • Insider trading
  • SEC Form 4
  • SEC Form 13D
Management10 years
  • Leadership team
  • Board of directors
  • SEC Form 10-K
  • SEC Form DEF 14A
Key Developments10 years
  • Company announcements
  • SEC Form 8-K

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Stepan Company is covered by 4 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Michael HarrisonSeaport Research Partners
Daniel RizzoSidoti & Company, LLC
Vincent AndersonStifel, Equities Research

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide